Quebec’s Safe Working Conditions for a Safe Maternity Experience Program: Survey of Consultant Physicians and Human Parvovirus B19 in Montreal-Centre
Référence bibliographique 
Koutsavlis, Athanasios Tom, Boivin, Jean-François, Simard, Robert et Rossignol, Michel. 2000. «Quebec’s Safe Working Conditions for a Safe Maternity Experience Program: Survey of Consultant Physicians and Human Parvovirus B19 in Montreal-Centre ». Revue canadienne de santé publique / Canadian Journal of Public Health, vol. 91, no 4, p. 260-262.
Intentions : « The objectives of this survey were to identify current treatment practices of requests involving human parvovirus B19 in Montreal and to identify factors that influence these practices. » (p. 260)
Échantillon/Matériau : « [...] we identified 19 occupational health physicians who treated preventive withdrawal-reassignment request in Montreal from October 1, 1998 to September 30, 1999. These physicians had a background in Family Medecine and/or training (specialization diploma, graduate degree) in Community/Occupational Medecine. The physicians practised in five CLSCs (Centre local de services communautaires) designated as occupational health service centres, and were sent a questionnaire by mail, to which all of them replied. Of the 19 physicians, only 11 treated requests involving B19, and these were retainded as our study population. » (p. 260)
Instruments : Questionnaire d’enquête
Type de traitement des données : Analyse de contenu
« Safe Maternity Experience is a prevention program instituted in Quebec in 1981 to maintain safe working conditions for the pregnant breastfeeding worker. [...] Throughout the province, consultant physicians in local occupational health teams treat requests for preventive withdrawal-reassignment. Recently, there has been an increasing number of requests involving human parvovirus B19 as a potential biologic risk factor in pregnancy. » (p. 260) This article contains the results of a survey that identify current treatment practices of requests involving human parvovirus B19 in Montreal.